New York, New York — January 30, 2026 — Leads & Copy — Chen Schor, President and CEO of Adicet Bio, Inc. (Nasdaq: ACET), will present at the Guggenheim Emerging Outlook: Biotech Summit 2026. The summit is scheduled to take place February 11-12, 2026, in New York.
The presentation is scheduled for Thursday, February 12, 2026, at 2:00 p.m. ET.
A live audio webcast will be available in the Investors section of Adicet Bio’s website.
An archived replay will be available on the website for 30 days following the presentation.
Adicet Bio, Inc. is a clinical stage biotechnology company focused on discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is developing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients.
Source: Adicet Bio, Inc.
